4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001231919-26-000231
Director bought 300,000 shares at $16.00 ($4,800,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-02-26 | Purchase | +300,000 | $16.00 | $4,800,000 | 4,603,418 | I |
| Derivatives | |||||||
| RA CAPITAL MANAGEMENT, L.P. Director | 2026-02-26 | Purchase · Pre-Funded Warrant (Right to Buy) | +2,200,000 | $16.00 | $35,199,780 | 2,200,000 | I |
| Open-market purchases · 300,000 sh · avg $16.00 · $4,800,000 | |||||||
Loading xslF345X05/form4-03022026_090351.xml…